Moritz Liebert is a finance professional with extensive experience in financial leadership and business management within the pharmaceutical and consulting industries. Currently serving as a Finance Enterprise Partner at Roche since November 2020, Moritz has played a key role in managing financial aspects of significant projects, including the Vacaville Divestment with a sales price of 1.2B CHF. Previously, as Head of Finance for Drug Substance Manufacturing at Roche, Moritz oversaw budgeting and strategic site decisions while managing global Capex responsibilities. Prior experience at Heraeus included leading teams in implementing standardized SAP FI/CO processes and analyzing budget deviations as Business Unit Controller. Moritz's background also includes roles as a Regional Financial Analyst and trainee in various financial functions. Moritz holds a Master's degree in Business Administration and Management from the Technical University of Munich.
This person is not in any teams
This person is not in any offices